Literature DB >> 15018862

Parainfluenza virus 3 infection pre- and post-haematopoietic stem cell transplantation: re-infection or persistence?

K E Templeton1, R G M Bredius, S A Scheltinga, E C J Claas, J M Vossen, A C M Kroes.   

Abstract

BACKGROUND: A 5-year-old boy with acute lymphoblastic leukaemia (ALL) received a haematopoietic stem cell transplant (HSCT) from his father and was monitored for the presence of respiratory viruses. STUDY
DESIGN: Nasal washes were taken during the transplant period and tested by culture and real-time PCR.
RESULTS: Fifteen days prior to transplant parainfluenza virus 3 (PIV3) was isolated by culture and confirmed by immunofluoresence (IF) from a nasal wash specimen. Subsequent samples were negative by both IF and culture so the pre-transplant conditioning was started. One week after the HSCT the patient developed respiratory symptoms which progressively deteriorated. The IF and culture for PIV3 became positive again only after the symptoms deteriorated. However, retrospectively, a real-time PCR assay showed that the PIV3 was detectable throughout the conditioning phase and the amount of virus increased at the time of reappearance of respiratory symptoms post-HSCT.
CONCLUSIONS: Management of PIV3 infection is important in HSCT. The use of this real-time PCR assay could improve diagnosis and management of PIV3 infection.

Entities:  

Mesh:

Year:  2004        PMID: 15018862     DOI: 10.1016/S1386-6532(03)00215-4

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  8 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation.

Authors:  Alpana Waghmare; Janet A Englund; Michael Boeckh
Journal:  Blood       Date:  2016-03-11       Impact factor: 22.113

3.  Diagnosis of Pediatric Acute Adenovirus Infections: Is a Positive PCR Sufficient?

Authors:  Eunkyung Song; Huanyu Wang; Adriana E Kajon; Doug Salamon; Siwen Dong; Octavio Ramilo; Amy Leber; Preeti Jaggi
Journal:  Pediatr Infect Dis J       Date:  2016-08       Impact factor: 2.129

4.  Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4.

Authors:  Hatice Hasman; Constance T Pachucki; Arife Unal; Diep Nguyen; Troy Devlin; Mark E Peeples; Steven A Kwilas
Journal:  J Med Microbiol       Date:  2009-04       Impact factor: 2.472

5.  Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.

Authors:  Angela J Peck; Janet A Englund; Jane Kuypers; Katherine A Guthrie; Lawrence Corey; Rhoda Morrow; Robert C Hackman; Anne Cent; Michael Boeckh
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113

6.  The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.

Authors:  Matt S Zinter; Caroline A Lindemans; Birgitta A Versluys; Madeline Y Mayday; Sara Sunshine; Gustavo Reyes; Marina Sirota; Anil Sapru; Michael A Matthay; Sandhya Kharbanda; Christopher C Dvorak; Jaap J Boelens; Joseph L DeRisi
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113

7.  Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant.

Authors:  Angela P Campbell; Katherine A Guthrie; Janet A Englund; Robert M Farney; Elisa L Minerich; Jane Kuypers; Lawrence Corey; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2015-04-05       Impact factor: 9.079

8.  Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone.

Authors:  Heba H Mostafa; Peter Vogel; Ashok Srinivasan; Charles J Russell
Journal:  PLoS Pathog       Date:  2016-09-02       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.